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Abstract
Background: Joint data analysis from multiple nutrition studies may improve the ability to answer complex questions
regarding the role of nutritional status and diet in health and disease.
Objective: The objective was to identify nutritional observational studies from partners participating in the European
Nutritional Phenotype Assessment and Data Sharing Initiative (ENPADASI) Consortium, as well as minimal requirements
for joint data analysis.
Methods: A predefined template containing information on study design, exposure measurements (dietary intake, alco-
hol and tobacco consumption, physical activity, sedentary behavior, anthropometric measures, and sociodemographic
and health status), main health-related outcomes, and laboratory measurements (traditional and omics biomarkers) was
developed and circulated to those European research groups participating in the ENPADASI under the strategic research
area of “diet-related chronic diseases.” Information about raw data disposition and metadata sharing was requested. A
set of minimal requirements was abstracted from the gathered information.
© 2018 American Society for Nutrition. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly
cited.
285Manuscript received August 24, 2017. Initial review completed September 21, 2017. Revision accepted November 6, 2017.
First published online February 27, 2018; doi: https://doi.org/10.1093/jn/nxx037.Downloaded from https://academic.oup.com/jn/article-abstract/148/2/285/4913031by Ghent University user
on 28 February 2018
Results: Studies (12 cohort, 12 cross-sectional, and 2 case-control) were identified. Two studies recruited children only
and the rest recruited adults. All studies included dietary intake data. Twenty studies collected blood samples. Data
on traditional biomarkers were available for 20 studies, of which 17 measured lipoproteins, glucose, and insulin and 13
measured inflammatory biomarkers. Metabolomics, proteomics, and genomics or transcriptomics data were available
in 5, 3, and 12 studies, respectively. Although the study authors were willing to share metadata, most refused, were
hesitant, or had legal or ethical issues related to sharing raw data. Forty-one descriptors of minimal requirements for the
study data were identified to facilitate data integration.
Conclusions: Combining study data sets will enable sufficiently powered, refined investigations to increase the knowl-
edge and understanding of the relation between food, nutrition, and human health. Furthermore, the minimal require-
ments for study data may encourage more efficient secondary usage of existing data and provide sufficient information
for researchers to draft future multicenter research proposals in nutrition. J Nutr 2018;148:285–297.
Keywords: nutritional phenotype, metadata, data integration, data sharing, observational studies
Introduction
The joint analysis of individual-level data from multiple nutri-
tion studies may improve the ability to answer complex ques-
tions in studying the role of diet and metabolism in health and
disease that individual studies are underpowered to examine
(1). Moreover, a joint individual-level data analysis, unlike in
study-level meta-analysis, offers the possibility to reuse data in
new ways by combining individual data from different studies,
thereby increasing the diversity of samples and the robustness
of statistical subgroup analyses (i.e., increasing statistical effi-
ciency and flexibility). This is particularly relevant for nutrition
studies on biomarkers, because their laboratory analysis is usu-
ally expensive and joint data analysis may provide an efficient
way of using existing biomarker data.
Although international research funders encourage shar-
ing data to maximize discovery and innovation in public
health, scientists are reluctant to engage in such initiatives.
Reasons for their concern range from intellectual property
rights to potential data misuse or misinterpretation, insufficient
participant privacy, confidentiality safeguards to scientists,
unfamiliarity with data management systems and metadata
standards, and general lack of scientific culture for data sharing
(2). In nutritional epidemiology, there are only a few examples
of successful implementation of data integration platforms
facilitating pooled analysis of individual-level data, including
the Nutritional Phenotype database (www.dbnp.org) (3) and
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the EURopean micronutrient RECommendations Aligned
(EURRECA) Network of Excellence (4). Yet, examples of joint
data analyses with regard to nutrition and biomarkers are
scarce (5).
A prerequisite to facilitating interpretation, comparison,
reproducibility, and reuse of data is the identification of
minimal information to add as metadata. Several initiatives
have developed minimal information checklists containing a
set of guidelines or recommendations for reporting data on
specific high-throughput experimental technologies that have
become a prerequisite for publication in journals (6–11). They
follow a hierarchical structure developed by the Investigation,
Study, and Assay (ISA) Commons (12), which is a growing
community that uses the ISA metadata categories tracking
framework to facilitate standards-compliant collection, cura-
tion, management, and reuse of data sets in an increasingly
diverse set of life science domains (13). These checklists pro-
vide access to a range of background information that may
help in interpreting results and having a better picture of the
context of the study as well as the methods used, data collected,
and conclusions drawn. So far, in the field of nutrition, only
Minimum Information About a Nutrigenomics Experiment
(MIAME/Nutr) was developed for array-based nutrigenomics
experiments, as an extension of the MIAME standards (Min-
imum Information About a Microarray Experiment) (14).
However, minimal information checklists for the integration of
data sets from nutritional epidemiologic studies are lacking.
The aim of this study was to identify epidemiologic obser-
vational studies with a wealth of data and metadata, particu-
larly on dietary assessment and traditional and omics biomark-
ers within the context of the European Nutritional Phenotype
Assessment and Data Sharing Initiative (ENPADASI). These
studies served as the basis for the identification of minimal
information, hereafter referred to as minimal requirements to
connect existing and future study (meta)databases and facili-
tate data exchange, data interpretation, and increasing the ro-
bustness of results from future joint data analysis in nutri-
tional epidemiology—and for infrastructures that support such
projects. In the present study, joint data analysis refers to ei-
ther “pooled,” if individual-level data from different studies are
stored in a single central database, or “federated,” if joint anal-
yses of individual-level data from several studies are conducted
without physically transferring their data into a single central
database.
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Methods
Consortium assembly
This study was conducted within the framework of ENPADASI,
a knowledge hub comprising 51 partners from 9 countries
that aim to provide the open-access Data Sharing Initiative for
Nutrition (DASH-IN) infrastructure with easy-to-follow instructions
for data- and metadata-sharing processes and tools to address political,
legal, and ethical barriers to enable joint data analyses (15, 16). It
was created in response to a call by the Joint Programming Initiative
“A Healthy Diet for a Healthy Life” (JPI-HDHL) within the strategic
research area of “diet-related chronic diseases” (17). Interested research
groups submitted an “Expression of Interest” letter to the Call Sec-
retariat and networked to develop the ENPADASI program proposal,
in which a list of studies (24 observational and 79 intervention or
mechanistic) potentially available within the appointed ENPADASI
members was provided.
Development of a tool for collecting study metadata
A template was developed to obtain meta-information from each iden-
tified observational study. The first version of the template was based
on the work conducted in task 2.1.2 “Explorative secondary data anal-
ysis and further development of the dynamic and evolving framework
of determinants of dietary behaviour” within the JPI-HDHL Determi-
nants of Diet and Physical Activity (DEDIPAC) project (18). This tem-
plate was then modified by a group of involved researchers to fit the
purposes of ENPADASI. The final template was circulated to those
ENPADASI partners who were concerned with identification of studies
and data collection, and was further extended to JPI-project DEDIPAC
partners. To include as many studies as possible, the inclusion criteria
were very broad: cohort, case-control, or cross-sectional studies with
data on nutrition (i.e., dietary assessment) and conducted in humans.
The template contained the following information: 1) general in-
formation on the study (name of study, study web links, funding body,
coordination center of the study), 2) scope of the study, 3) study design
and recruitment, 4) exposure measurements (dietary intake, alcohol and
tobacco consumption, physical activity, sedentary behavior, anthropo-
metric measurements, sociodemographic information, and health sta-
tus), 5) main health-related outcome, and 6) laboratory measurements
in biological samples (traditional biomarkers as well as omics biomark-
ers, such as proteomics, genomics, transcriptomics, and metabolomics).
In addition, the template ascertained information on signed informed
consents, ethics committee approval, and potential raw and metadata
sharing (within and outside the ENPADASI consortium).
The template was circulated to the principal investigators from the
24 observational studies that expressed their interest when the call
was launched. In addition, the template was circulated among the EN-
PADASI partners to identify more studies. The partners filled in the re-
quested information for the respective study and returned the complete
templates to the Max Delbrück Center for Molecular Medicine, where
they were kept and aggregated into a final list of observational studies
for integration in ENPADASI.
Identification of minimal requirements described in
the form of a checklist
The concept of minimal requirements was defined in ENPADASI as the
description of a set of metadata descriptors sufficient for clear interpre-
tation and use of data, to improve study comparability, and finally, to
aid in the development of reusable data-quality metrics. The founda-
tion of the research infrastructure that is currently being created by the
ENPADASI initiative is built on minimal requirements to which data
should comply (including the necessary information on study design,
endpoints, other measurements, data ownership, data availability, and
ethical limitations).
To identify the minimal requirements for observational studies meta-
data entry, we followed the hierarchical structure developed by the ISA
Commons (12). The “investigation” category describes the project con-
text; the “study” category describes a unit of research, describing the
subjects of study and how they are obtained; and the “assay” cate-
gory describes any analytical measurement. We developed a checklist
structure following the 3 ISA categories. The checklist was also devel-
oped in close collaboration with the researchers leading the develop-
ment of study-quality descriptors for data from nutritional epidemi-
ologic research described elsewhere (19) to avoid overlap. Briefly, the
study-quality descriptors were identified after a literature review, a face-
to-face meeting to discuss the descriptors found in the literature, and a
consensus meeting to decide on the essential study-quality descriptors.
The difference between the minimal requirements descriptors and the
study-quality descriptors is that the former are mandatory and the lat-
ter are an optional set of questions. Both minimal requirements and
study-quality descriptors (19) define the meta-database in ENPADASI.
Results
We identified 26 observational nutrition studies (20–47) con-
ducted in Germany (n= 8), Italy (n= 6), Belgium (n= 5), Spain
(n = 3), Ireland (n = 2), and Estonia (n = 2) (Table 1 ). The
study designs were longitudinal (n = 12 cohort studies), cross-
sectional (n = 12), and case-control (n = 2) studies. Twenty-
two studies were population-based. Four were patient-based, of
which 1was a case-control study (41), 2 were cohort studies (31,
44), and 1 was a cross-sectional study (32). Twenty-four studies
recruited adults, of which 7 also recruited subjects aged <18 y.
Two longitudinal studies (23, 29, 30) recruited children only.
Of the 26 observational studies, 4 are still ongoing (23, 29, 30,
33, 41) and 3 longitudinal studies recently started [Hamburg
City Health Study (HCHS) and the German National Cohort
(NAKO Gesundheitsstudie); Diet4MicroGut, Italy].
The information related to the following sections is based on
the metadata provided in the templates and grouped according
to the study design.
Assessment of exposures: dietary intake and
covariates
Table 2 describes the studies with information on dietary
intake and other covariates. All of the studies collected infor-
mation on dietary intake, alcohol and tobacco consumption,
physical activity, anthropometric measurements, socioeconomic
status, and health status, with the exception of 1 case-control
study (41) that had no data on tobacco consumption, 1 longi-
tudinal study (44) that had no data on physical activity, and
1 cross-sectional study (40) that had no data on health sta-
tus (Supplemental Table 1). Furthermore, all of the studies had
data on health status, mainly on prevalent chronic diseases such
as cardiovascular disease, cancer, diabetes, respiratory disease,
chronic infectious disease, and neurodegenerative disease.
Case-control studies. Of the 2 studies from Italy, 1 collected
information on dietary intake by using a semiquantitative FFQ,
whereas the other study used food records obtained by self-
completed questionnaires (Table 2).
Both studies had subjective data on physical activity, but
only one also used accelerometers. One collected data on seden-
tary behavior objectively (35). Anthropometric measurements
including weight and height were objectively measured in both
studies, and one study also measured waist and hip circumfer-
ence (Supplemental Table 1).
Cohort studies. Twelve studies collected information on di-
etary intake in the form of multiple (n = 3) 24-h dietary re-
calls, semiquantitative (n = 7) or qualitative (n = 1) FFQs, and
food records (n= 4). Twenty-four-hour dietary recalls were con-
ducted after face-to-face (n = 1) and telephone (n = 1) inter-
views or by self-completed questionnaires (n = 1). FFQs were
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TABLE 1 List of the observational studies identified within the ENPADASI consortium1
Study (reference) Country Institution Study design Sample size, n (M/F)
Recruitment
years Target population
Food Consumption Survey 2014 (22) Belgium Scientific Institute of
Public Health
(WIV-ISP)
Cross-sectional 3200 (1600/1600) 2014–2015 General population; aged
3–64 y at recruitment
Health Interview Survey (25) Belgium Scientific Institute of
Public Health
(WIV-ISP)
Cross-sectional 10,600 (5300/5300) 2013 General population, aged
0–100 y at recruitment
NESCaV (21) Belgium University of Liège Cross-sectional 1000 (500/500) 2010–2012 General population, aged
20–69 y at recruitment
Equilibre Alimentaire ou Equilibre
Aliment-Terre? (40)
Belgium University of Liège Cross-sectional 188 (89/99) 2012 General population, aged
30–40 y at recruitment
INOGMA (44) Belgium University Hospitals
Leuven
Cohort 54 (21/33) 2012–2014 Obese patients who had
planned RYGB surgery at
University Hospitals
Leuven, Belgium; aged
18–60 y at recruitment
Baltic Nutrition and Health Survey (42) Estonia NIHD Cross-sectional 2108 (902/1116) 1997 General population, aged
19–65 y at recruitment
National Dietary Survey 2014 (46, 47) Estonia NIHD Cross-sectional 5031 (1843/3188) 2013–2015 General population, aged 3
mo–74 y at recruitment
NAKO (20) Germany Nationale Kohorte eV Cohort Expected: 200,000
(100,000/100,000)
2014 (ongoing) General population, aged
20–69 y at recruitment
ActivE-Study2 Germany MDC Cross-sectional 50 (25/25) 2012–2014 General population, aged
20–69 y at recruitment
BVS II (36) Germany HMGU Cross-sectional 1050 (442/608) 2002–2003 General population (German
speaking), aged 13–80 y at
recruitment
NVS II (45) Germany MRI Cross-sectional 19,329 (8923/10,406) 2005–2007 General population, aged
14–80 y at recruitment
DONALD (23) Germany University of Bonn Cohort ∼1500 (750/750) Since 1985
(ongoing)
General population, aged 3
mo at recruitment
EPIC–Potsdam substudy (39) Germany DIfE Cohort 815 (412/403) 2010 General population, aged
47–81 y at recruitment
GINIplus (29)/LISAplus (30) Germany HMGU Cohort3 GINIplus: 5991
(2991/2839)
LISAplus: 3094
(1584/1510)
GINIplus:
1995–1998
(ongoing)
LISAplus:
1997–1999
(ongoing)
General population, recruited
at birth
HCHS2 Germany UKE Cohort 45,000
(22,500/22,500)
Since May 2015 General population, aged
45–74 y at recruitment
TUDA (31) Ireland TCD; University of
Ulster, Coleraine
Cohort 5186 (1699/3487) 2008–2012 Noninstitutionalized adults
from either hospital clinics
or the community, in
subcohorts to focus on 3
common diseases of aging:
cognitive dysfunction, bone
disease, or hypertension;
aged 60–102 y at
recruitment
NANS (26) Ireland UCC; UCD Cross-sectional 1500 (740/760) 2008–2010 General population
(nonpregnant/lactating),
aged >18 y at recruitment
NU-AGE (35) Italy University of Bologna Case-control 1272 (557/715) 2012–2016 General population, free of
major overt diseases; aged
65–79 y at recruitment
(Continued)
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TABLE 1 Continued
Study (reference) Country Institution Study design Sample size, n (M/F)
Recruitment
years Target population
PRED-CC (41) Italy ISS Case-control 48 (18/30) 2014–2016 Subjects undergoing
abdominal surgery for
colon cancer or benign
conditions; aged 28–78 y
at recruitment
INGI-FVG (33) Italy IRCCS Burlo Garofolo Cohort 1444 (610/834) Ongoing General population, aged
18–99 y at recruitment
INGI-CARL (37) Italy IRCCS Burlo Garofolo Cohort 538 (223/315) 2008 General population, aged
18–99 y at recruitment
SR (34) Italy IRCCS Burlo Garofolo Cohort 692 (270/422) 2010–2013 General population, aged
18–99 y at recruitment
Diet4MicroGut (43) Italy UNIBA Cohort 161 (67/94) 2013/2014 General population, aged
18–55 y at recruitment
Di@bet.es study (28) Spain CIBERDEM Cross-sectional ∼5000 (2000/3000) 2008–2010 General population, aged
18–100 y at recruitment
Pizarra study (38) Spain CIBERDEM Cohort ∼900 (360/540) 1996–2007 General population, aged
18–65 y at recruitment
METBANC (32) Spain CIBERDEM Cross-sectional ∼700 (250/450) 2007–2014 Patient-based study: patients
at increased cardiovascular
risk; aged 20–70 y at
recruitment
1The general population includes both random and convenience sampling designs. BVS II, Bavarian Food Consumption Survey II; CIBERDEM, Center in Diabetes and Associated
Metabolic Disorders; DIfE, German Institute of Human Nutrition; DONALD, DOrtmund Nutritional and Anthropometric Longitudinally Designed Study; ENPADASI, European
Nutritional Phenotype Assessment and Data Sharing Initiative; EPIC, European Prospective Investigation in Cancer and Nutrition; GINIplus, German Infant Study on the Influence
of Nutrition Intervention; HCHS, Hamburg City Health Study; HMGU, Helmholtz Zentrum München–German Research Center for Environmental Health; INGI-CARL, Italian
Network of Genetic Isolates–Carlantino; INGI-FVG, Italian Network of Genetic Isolates–Friuli Venezia Guilia; INOGMA, Influence of Obesity and Gastric Bypass on Medication
Absorption; IRCCS, Istituto di Ricovero e Cura a Carattere Scientifico; ISS, Istituto Superiore di Sanità; LISAplus, Influences of Lifestyle-Related Factors on the Human Immune
System and Development of Allergies in Children; MDC, Max Delbrueck Center for Molecular Medicine in the Helmholtz Association; METBANC, Clinical and Genetic Study
of Patients with Major Cardiovascular Rick Factors; MRI, Max Rubner-Institut–Federal Research Institute of Nutrition and Food; NAKO, National Cohort; NANS, National Adult
Nutrition Survey; NESCaV, Nutrition, Environment, and Cardiovascular Health; NIHD, National Institute for Health Development; NU-AGE, New Dietary Strategies Addressing the
Specific Needs of an Elderly Population for Healthy Aging in Europe; NVS II, German National Nutrition Survey II; PRED-CC, Predicting Tumor Development Risk by an Integrated
Approach Liking Diet-Related Inflammation to Colon Cancer; RYGB, Roux-en-Y gastric bypass; SR, Silk Road; TCD, Trinity College Dublin; TUDA, The Trinity, Ulster, Department
of Agriculture aging cohort study; UCC, University College Cork; UCD, University College Dublin; UKE, University Medical Centre Hamburg-Eppendorf; UNIBA, University of Bari
Aldo Moro; WIV-ISP, Wetenschappelijk Instituut Volksgezondheid - Institut Scientifique de Santé Publique.
2No reference available.
3GINIplus and LISAplus are 2 German birth cohorts whose data will be pooled to increase statistical power as methods are harmonized.
equally conducted after face-to-face interviews (n = 4) or self-
completed questionnaires (n = 4), and food records were ob-
tained by self-completed questionnaires (n = 2) or face-to-face
interviews (n = 2). One Italian study (43) collected informa-
tion on dietary intake by using all 3 instruments in a subset of
participants (Table 2). Two studies used a self-completed ques-
tionnaire to collect data on food preferences (34, 37).
Eleven studies had subjective data on physical activity,
of which 4 also used accelerometers. Three studies collected
data on sedentary behavior, of which 1 collected subjective
data only (24), and 2 collected both subjective and objective
data (29, 30, 39). Anthropometric measurements, including
height, weight, and waist and hip circumference measurements,
were objectively measured in 11 studies. In addition, 2 stud-
ies measured these variables subjectively (self-reported) (Sup-
plemental Table 1).
Cross-sectional studies. Twelve studies collected information
on dietary intake, mainly in the form of multiple (n = 4)
or single (n = 2) 24-h dietary recalls, semiquantitative (n =
4) or qualitative (n = 2) FFQs, and food records (n = 6).
Twenty-four-hour dietary recalls were conducted after face-to-
face (n = 4) and telephone (n = 2) interviews. FFQs were
equally conducted after face-to-face interviews (n = 4) or
self-completed questionnaires (n = 4), and food records were
obtained by self-completed questionnaires (n = 2) or face-to-
face interviews (n = 1). Three studies (32, 43, 46, 47) col-
lected information on dietary intake by using all 3 instru-
ments in at least a subset of participants. Three studies used
additional questions to collect data on dietary intake: the
German National Nutrition Survey II (NVS II) study from
Germany (45) applied 24-h dietary recalls, diet history inter-
views, and weighing records; the Bavarian Food Consumption
Survey II (BVS II; Germany) (36) asked a set of questions con-
cerning nutritional knowledge; and the Health Interview Survey
(Belgium) (25) asked questions on food consumption (Table 2).
All of the studies had subjective data on physical activity,
of which 3 also used accelerometers. Eight studies collected
data on sedentary behavior, of which 6 collected data sub-
jectively only (21, 26, 36, 42, 45–47), and 2 also collected
objective data [Food Consumption Survey 2004/2014 (23),
Belgium; ActivE-Study, Germany]. Anthropometric measure-
ments, including height, weight, and waist and hip circumfer-
ences, were subjectively measured in 7 studies (self-reported)
and objectively measured in 11 studies (Supplemental Table 1).
Biological samples and laboratory measurements
Case-control studies. The studies had a variety of traditional
and omics biomarkers available (Table 3). NU-AGE and PRED-
CC studies (35, 41) collected blood (serum, plasma), of which
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TABLE 2 Dietary intake assessments conducted in the observational studies participating in
ENPADASI1
Study Country 24-h recall FFQ Food records Other
Food Consumption Survey
2014
Belgium M  Qual. — —
Health Interview Survey Belgium — — — 
INOGMA Belgium — —  —
NESCaV Belgium —  SQ — —
Équilibre Alimentaire ou
Équilibre Aliment-Terre?
Belgium —  SQ — —
Baltic Nutrition and
Health Survey 1997
Estonia  S — — —
National Dietary Survey
2014
Estonia M  SQ  —
NAKO Germany M  SQ — —
ActivE Germany — —  —
BVS II Germany M — — 
NVS II2 Germany M —  
DONALD Germany — —  —
HCHS Germany —  SQ — —
GINIplus and LISAplus Germany —  SQ — —
EPIC-Potsdam substudy Germany M  SQ — —
TUDA Ireland —  SQ — —
NANS Ireland — —  —
NU-AGE Italy — —  —
PRED-CC Italy —  SQ — —
INGI-FVG Italy —  SQ — —
INGI-CARL Italy — — — 
SR Italy — — — 
Diet4MicroGut Italy M  SQ  —
Di@bet.es Spain —  Qual — —
Pizarra Spain —  Qual  —
METBANC2 Spain  S  SQ  —
1BVS II, Bavarian Food Consumption Survey II; DONALD, DOrtmund Nutritional and Anthropometric Longitudinally Designed
Study; ENPADASI, European Nutritional Phenotype Assessment and Data Sharing Initiative; EPIC, European Prospective Inves-
tigation into Cancer and Nutrition; GINIplus, German Infant Study on the Influence of Nutrition Intervention; HCHS, Hamburg
City Health Study; INGI-CARL, Italian Network of Genetic Isolates–Carlantino; INGI-FVG, Italian Network of Genetic Isolates–
Friuli Venezia Giulia; INOGMA, Influence of Obesity and Gastric Bypass on Medication Absorption; LISAplus, Influences of
Lifestyle Related Factors on the Human Immune System and Development of Allergies in Children; M, multiple; METBANC,
Clinical and Genetic Study of Patients with Major Cardiovascular Risk Factors; NAKO, German National Cohort; NANS, National
Adult Nutrition Survey; NESCaV, Nutrition, Environment and Cardiovascular Health; NU-AGE, New Dietary Strategies Address-
ing the Specific Needs of an Elderly Population for Healthy Aging in Europe; NVS II, German National Nutrition Survey II; Qual,
qualitative; PRED-CC, Predicting Tumor Development Risk by an Integrated Approach Linking Diet-Related Inflammation to
Colon Cancer; S, single; SQ, semiquantitative; SR, Silk Road; TUDA, Trinity, Ulster, Department of Agriculture aging cohort
study; , dietary measurement available/collected.
2Not all the dietary measurements were available for all of the included participants.
one also collected urine and feces, and the other collected adi-
pose tissue. Overall, traditional biomarkers were available in
both studies. Lipids and lipoproteins (mainly HDL cholesterol,
LDL cholesterol, and total cholesterol) and glucose and insulin
(glucose and insulin in serum and glycated hemoglobin (HbA1c)
in EDTA plasma) were measured in 1 study. Both studies had
data on inflammatory markers such as IL-6 and TNF-α, but
only one had data on C-reactive protein (CRP). Both studies
had data on adipokines, such as adiponectin, although one mea-
sured this in serum and the other in adipocytes from adipose
tissue biopsy samples. One study had data on leptin in either
serum or plasma. Further details on biomarkers are described in
Supplemental Tables 2–6.
Metabolomics, proteomics, and genomics and transcrip-
tomics were available only in one of the studies. With re-
gard to metabolomics, 1 study applied NMR and MS for con-
centration measurements in blood (serum, plasma) and urine
(Supplemental Table 6). One study performed proteomic
analyses. Although both studies had DNA available, only one
collected genetic information by whole-genome sequencing
(Table 3).
Longitudinal studies. All of the studies collected biologi-
cal samples for measurements. Eleven studies collected blood
(serum, plasma), 7 collected urine, 5 collected saliva, 2 col-
lected feces, and 1 collected nasal swabs. These studies had a
variety of traditional and omics biomarkers available (Table
3). Overall, traditional biomarkers, metabolomics, proteomics,
and genomics and transcriptomics were available in 10, 3,
1, and 6 of the studies, respectively. With regard to lipids
and lipoproteins, 9 studies measured HDL cholesterol, 9 col-
lected LDL cholesterol, 10 collected total cholesterol, and
4 collected TGs. Glucose and insulin in serum were mea-
sured in 8 and 4 studies, respectively. HbA1c in EDTA
plasma was measured in 3 studies. Five studies had data
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TABLE 3 Measurements assessed in samples from the observational studies participating in ENPADASI1
Biomarker measurements Genomics/transcriptomics
Study name Country L G/I INFL A Other Metabolomics Proteomics SNPs GW data
Food Consumption Survey
2014
Belgium — — — — — — — — —
Health Interview Survey Belgium — — — — — — — — —
INOGMA Belgium    — — — — — —
NESCaV Belgium    —  — — — —
Équilibre Alimentaire ou
Équilibre Aliment-Terre?
Belgium — — — — — — — — —
Baltic Nutrition and
Health Survey 1997
Estonia — — — — — — — — —
National Dietary Survey
2014
Estonia — — — — — — — — —
NAKO Germany   — — — — — — —
ActivE2 Germany    — — — — — —
BVS II Germany      — —  —
NVS II Germany — — — — — — — — —
DONALD Germany     — — — — —
HCHS2 Germany   — — — — — — —
GINIplus and LISAplus Germany      — — — —
EPIC-Potsdam substudy2 Germany   — — —  — — —
TUDA Ireland    —  — —  —
NANS Ireland         —
NU-AGE Italy         —
PRED-CC Italy — —    — — — 
INGI-FVG Italy   — — —  — — 
INGI-CARL Italy   — — — — — — 
SR Italy — — — — — — — — 
Diet4MicroGut3 Italy — — — — —   — 
Di@bet.es Spain    —  — —  —
Pizarra Spain      — —  —
METBANC Spain      — —  —
1A, adiposity; BVS II, Bavarian Food Consumption Survey II; DONALD, DOrtmund Nutritional and Anthropometric Longitudinally Designed Study; ENPADASI, European Nutritional
Phenotype Assessment and Data Sharing Initiative; EPIC, European Prospective Investigation into Cancer and Nutrition; G/I, glucose/insulin; GINIplus, German Infant Study on
the Influence of Nutrition Intervention; GW, genome-wide; HCHS, Hamburg City Health Study; INFL, inflammatory; INGI-CARL, Italian Network of Genetic Isolates–Carlantino;
INGI-FVG, Italian Network of Genetic Isolates–Friuli Venezia Giulia; INOGMA, Influence of Obesity and Gastric Bypass on Medication Absorption; L, lipids; LISAplus, Influences of
Lifestyle Related Factors on the Human Immune System and Development of Allergies in Children; METBANC, Clinical and Genetic Study of Patients with Major Cardiovascular
Risk Factors; NAKO, German National Cohort; NANS, National Adult Nutrition Survey; NESCaV, Nutrition, Environment and Cardiovascular Health; NU-AGE, NewDietary Strategies
Addressing the Specific Needs of an Elderly Population for Healthy Aging in Europe; NVS II, German National Nutrition Survey II; PRED-CC, Predicting Tumor Development Risk by
an Integrated Approach Linking Diet-Related Inflammation to Colon Cancer; SNP, single nucleotide polymorphism; SR, Silk Road; TUDA, Trinity, Ulster, Department of Agriculture
aging cohort study; , Measurement assessed.
2DNA available but no measurements done.
3GWAS, Genome-wide associations; SNPs, Measurements other than single nucleotide polymorphisms.
on inflammatory markers, of which 4 measured CRP, IL-6
(n = 3), and TNF-α (n = 1), among others. Two studies had
data on adipokines such as adiponectin or leptin in either serum
or plasma. Further details on biomarkers are described in Sup-
plemental Tables 2–6.
With regard tometabolomics (n= 3), 2 studies appliedNMR
for concentration measurements in serum (n = 1) and in urine,
saliva, or feces (n = 1). The latter also applied MS in serum
urine, saliva, or feces (Supplemental Table 6). One study mea-
suredmetabolomics using AbsoluteIDQ p180 kit (Biocrates Life
Sciences AG, Innsbruck, Austria) in plasma from a targeted
group. Two of the 8 studies with DNA available have not yet
performed any genotyping or genomic measurements [HCHS
and European Prospective Investigation into Cancer and Nutri-
tion (EPIC)–Potsdam substudy, Germany]. However, 6 studies
had available genetic information by either whole-genome se-
quencing (n = 4) or candidate single nucleotide polymorphisms
(n = 2) (Table 3). One study (Diet4MicroGut, Italy) also per-
formed metagenomic analyses with available DNA.
Cross-sectional studies. Six studies did not collect biologi-
cal samples for measurements (22, 25, 40, 42, 45–47) and thus
had no biomarker data available (Table 3). The other 6 col-
lected blood (serum, plasma), of which 4 collected urine and
1 study collected hair. These studies had a variety of traditional
and omics biomarkers available (Table 3). Overall, traditional
biomarkers, metabolomics, proteomics, and genomics and tran-
scriptomics were available in 5, 1, 1, and 4 of the studies, respec-
tively.With regard to lipids and lipoproteins, 6 studies measured
HDL cholesterol and 5 measured LDL cholesterol, of which 1
had information on LDL cholesterol through calculation and 5
measured total cholesterol. Moreover, 3 of these studies mea-
sured TGs (n = 3). Five studies measured glucose and insulin
in serum, and 4 studies measured HbA1c in EDTA plasma. Five
studies had data on inflammatory markers such as CRP (n = 6),
IL-6 (n = 4), and TNF-α (n = 4), among others. Three studies
had data on adipokines such as adiponectin or leptin in either
serum or plasma. Further details on biomarkers are described
in Supplemental Tables 2–6.
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Metabolomics, proteomics and genomics assessments are
listed in Table 4 . One study (26) applied NMR for concen-
tration measurements in urine. The same study performed pro-
teomic analyses. One of the 5 studies with DNA available had
not yet performed any genotyping or genomic measurements
(ActivE-Study, Germany). However, 4 studies had available
genetic information by candidate single nucleotide polymor-
phisms (Table 3).
Informed consent, ethics, and data sharing
All of the identified observational studies indicated that their
study was approved by an ethics committee or by the Na-
tional Data Protection Office (45) (Supplemental Table 7). All
of the studies provided informed consent, with the exception of
the Belgian Health Interview survey (25), for which informed
signed consents were not required. Only 4 studies expressed a
clear interest in storing and sharing raw data within the EN-
PADASI consortium, whereas 4 declared that they probably
would. Three were likely to share data upon confirmation from
the study board or an agreement form. Four studies agreed to
partially share data. Eleven studies were not keen on storing
or sharing raw data within the consortium, partially due to
uncertainties related to ethics, data protection issues, and pri-
vacy, especially for the ongoing cohort studies. Some of these
are still internally discussing the possibility of sharing. With re-
gard to metadata, most of the studies agreed to share metadata
for future joint data analysis within a federated database system,
whereas 5 need confirmation.
Minimal requirements checklist
Table 4 describes a set of mandatory descriptors, totaling 41,
following the ISA categories. The Investigation category con-
tains 12 descriptors devoted to collecting metadata about the
project context, informed consent and ethical issues (descriptors
1–7), data-sharing policy (descriptors 8–11), and data analysis
permissions (descriptor 12). The Study category describes a set
of 12 descriptors about the study design (descriptors 1–2), study
subjects (descriptors 3–5 and 12), and recruitment (descriptors
6–11). The Assay category with 17 descriptors describes end-
points (descriptors 1–10), study samples (descriptors 11–14),
and analytical measurements (descriptors 15–17).
Discussion
We identified 26 observational studies conducted in 6 European
countries with data on dietary intake, biomarkers, and health
outcomes. Their design was mainly cross-sectional or longitu-
dinal. Most of the studies included adults, mainly from the gen-
eral population. All of the studies had data on dietary intake,
and 20 studies collected samples such as blood (serum, plasma),
urine, or saliva, which are the most commonly used to mea-
sure omics biomarkers (48). Although most of the 20 studies
had data on lipoproteins and glucose and insulin biomarkers
available,metabolomics or proteomics profiles were determined
less often and in different biological samples. Our results are
in agreement with the fact that the methodology used for ge-
nomics is relatively mature, whereas the methodology used for
the metabolome is still in its infancy (48, 49). From these stud-
ies, we identified a set of minimal requirements that each study
should provide when uploading their study metadata into a
metadatabase to allow for interpretation and comparability of
the data.
The identified studies are heterogeneous in their design
and used various types of dietary assessment methodolo-
gies. Nonetheless, we identified observational studies with
comparable data on traditional biomarkers. To study nutri-
tional phenotypes, diet-related subsets of metabolites, genes,
and proteins can be used as biomarker profiles (49). Our stud-
ies collected limited and diverse omics data, which, at a first
glance, may preclude the possibility to compare or join these
types of data. The scarce omics data from the identified studies
may be due to the current limitations in multi-omics integration
(i.e., the cost of omics methodologies, computational integra-
tion of multidimensional omics data, and the diversity of sam-
ples used, which largely depends on the study aims and techni-
cal issues). Yet, 2 Italian studies (35, 43) measured metabolites
by using both NMR and MS in urine samples, which may al-
low for comparability. In addition, a third study (26) from Ire-
land measured metabolites by using NMR in urine. The same
3 studies (26, 35, 43) also collected data on proteomics and
genomics so that nutritional phenotypes could be character-
ized together with data related to anthropometrics and func-
tional measures, such as physical activity, in the future. These
results highlight the importance of including high-throughput
technology approaches in nutritional epidemiology studies to
better investigate the diet-health relation through joint data
analysis.
The scientific community is increasingly pooling information
from multiple studies to construct large databases (50). How-
ever, if subtle changes or differences are to be captured, stan-
dardized methodology and data formats are required (5). There
are many ways to overcome such challenges, one of which is
by means of data harmonization approaches. In the case of di-
etary intake, the use of standardized methodology may be help-
ful to collect more comparable data and to minimize residual
confounding. However, the challenge remains when exploring
regional differences in nutrition behavior.Thus, standardized re-
gional nutrient databases are needed to reflect country-specific
products. Because our results showed that data owners were
reluctant to share raw data, we had to design a simple step-
wise process for the generation of harmonized databases that
can easily be implemented in future federated data analyses: 1)
consensus in the selection and definition of the list of variables
requested in the research proposal to be circulated among the
participating study partners in the form of a variable catalog,
2) generation of databases by using the variables and the ex-
act variable names and format measures described in the vari-
able catalog for study integration, and 3) creation of data dic-
tionaries for each participating study. Data dictionaries derived
from approved scientific research proposals will be stored in the
metadatabase together with the successful research proposal as
part of the uploaded files requested in the minimal requirements
(Investigation category, descriptor 7). Cataloging such informa-
tion will allow researchers to have an idea of the level of both
homo- and heterogeneity across study designs as well as poten-
tial sample sizes available for analyses for future research pro-
posals (51).
The identification of 41 minimal descriptors, together with
the 32 study-quality descriptors, will facilitate the integration of
data sets and enable querying the meta-information of studies
stored in centralized repositories for future research proposals.
In addition, the identified descriptors for minimal requirements
were used to develop the Ontology for Nutritional Studies (52).
The Ontology for Nutritional Studies aims to define a common
language (controlled vocabulary) for study metadata as well as
standardizing existing ontologies to facilitate data integration.
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TABLE 4 Checklist for minimal requirements for study metadata1
Number Descriptors Options Type
Investigation
1 Full name of the study Acronym if applicable Fill in the blank
2 Country of the study — Fill in the blank
3 Description of the study aim within the investigation — Fill in the blank
4 Principal investigator (name) for the study described — Fill in the blank
5 Contact information of the contact person of the
study/experiment
— Fill in the blank
6 Funding body/bodies for the investigation — Fill in the blank
7 Upload if available, or provide the URL Study web link for the investigation or study (URL) Multiple choice
Registration number of the study (i.e., clinicaltrials.gov) —
IRB/IEC approval number —
Informed consent —
Study protocol and any protocol deviation/amendments —
Questionnaires —
SOPs for samples collection —
Publications: type and DOI or file location —
Other: Please specify type of document (i.e., data
dictionaries and research proposals)
—
8 Data-sharing policy: study terminated Yes/no/ongoing Multiple choice
If ongoing, when are data going to be available?
(DD/MM/YYYY)
—
9 Data-sharing policy: data Publicly accessible Multiple choice
Not publicly accessible but available upon request —
Not publicly accessible —
10 Aggregate data-sharing policy (i.e., descriptive statistics) Publicly accessible Multiple choice
Not publicly accessible but available upon request —
Not publicly accessible —
11 Metadata Publicly accessible Multiple choice
Not publicly accessible but available upon request —
Not publicly accessible —
12 Data analysis permission With access to the raw data Multiple choice
Without access to the raw data (federated analysis) —
Study
1 Study design Cohort Multiple choice
Cross-sectional —
Case-control —
Seroepidemiologic study —
Other: please specify study design —
2 Provide a short description of the study — Fill in the blank
3 Study population Recruited from the general population Multiple choice
No —
4 Particular dietary, physiologic, or nutritional
characteristics of target population
— Fill in the blank
5 Population representativeness National level (nationally representative) Multiple choice
Subnational level (covers multiple communities. i.e.,
>3 cities, >5 villages, or ≥1 provinces or states)
—
Community level —
6 Type of sampling Probability sampling: Multiple choice
-Simple random sampling —
-Stratified random sampling —
-Multistage sampling —
Nonprobability sampling:
-Voluntary response sampling —
-Judgement sampling —
-Convenience sampling —
-Other: describe —
(Continued)
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TABLE 4 Continued
Number Descriptors Options Type
7 Describe control group — Fill in the blank
8 Describe type of controls — Fill in the blank
9 Start/end of recruitment DD/MM/YYYY–DD/MM/YYYY Fill in the blank
10 Follow-ups Describe time points and actions taken Fill in the blank
11 Total number of participants recruited Total; M; F Fill in the blank
12 Age range of the study participants — Fill in the blank
Assay
1 Method for dietary or nutritional assessment Dietary records (innovative alternatives:
PDA-technologies, mobile phone–based technologies,
camera- and tape recorder–based technologies)
Multiple choice
24-h recall (innovative alternatives:
interactive computer-based technologies, Web-based)
—
Screener/FFQ (innovative alternatives:
interactive computer-based technologies, Web-based):
—
-Qualitative (only frequency) —
-Semiquantitative —
-Quantitative —
Diet history —
Other: please specify —
2 Reference of the main food-composition
table used (or URL)
— Fill in the blank
3 Type of food assessed Food Multiple choice
Drinks —
Dietary supplements —
4 Nutrient and food intake data Unadjusted (preferred option) Multiple choice
Adjusted for total energy intake using: —
1. Density method —
2. Residual method —
Estimates of usual intake from short-term
measurements
—
Other: describe —
5 Physical activity Objective measurement Multiple choice
Name of the tool, provider, version, year of
the version
questions & Fill in
the blank
Subjective measurement —
Name of the questionnaire, provider, version,
year of the version
—
6 Tobacco use Yes/no Multiple choice
7 Alcohol consumption Yes/no Multiple choice
8 Anthropometry Weight Multiple choice
Height —
Waist circumference —
BMI status (categories) —
Body fat percentage —
9 Sociodemographic information Yes/no Multiple choice
10 Study outcomes and time points of assessment:
health outcomes
— Fill in the blank
11 Total number of sample donors (number of
individuals with biological samples)
— Fill in the blank
12 Type of biological samples and total number of
sample donors per sample type
Whole blood Multiple choice
Serum —
Plasma —
Urine —
Saliva —
Feces —
Other: please specify —
13 Fasting Yes/no Multiple choice
14 Relative time points of sampling event — Fill in the blank
(Continued)
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TABLE 4 Continued
Number Descriptors Options Type
15 Type of omics Biomarkers Multiple choice
Metabolomics —
Proteomics —
Genomics —
Transcriptomics —
16 Measurement (i.e., metabolite profiling) — Fill in the blank
17 Technology (i.e., MS, chromatography) — Fill in the blank
1DD/MM/YYYY, date/month/year; IRB/IEC, Institutional Review Board/Independent Ethics Committee; PDA, Personal Digital Assistant; SOP, Standard Operating
Procedure.
Study metadata should be made available for data analysis for
a positive and long-lasting impact on the value of collective sci-
entific outputs (5). However, minimal requirements should be
succinct enough to facilitate practical reporting without losing
detail.
The ENPADASI consortium is currently developing a meta-
database with the use of Mica (53), a software tool designed by
the Maelstrom Research Group (www.maelstrom-research.org)
using the OBiBa (Open Source Software for BioBanks) soft-
ware suite (http://www.obiba.org/) that allows cataloging the
collected observational studies through their metadata. The
mandatory minimal requirements together with the optional
quality descriptors (19) have been uploaded in Mica (54). The
DASH-IN system currently has a central platform for metadata
(Mica) server in Bari (54), enabling the retrieval of study meta-
data from a stable location. Users can interrogate or interpret
metadata from the identified studies by means of an initial set of
ontologies in agreement with the FAIR principles to ensure that
the data is Findable, Accessible, Interoperable, and Reusable
(15). A strength of the ENPADASI consortium is that we have
direct contact with data managers, allowing for more trans-
parency. Data managers are in charge of uploading the required
metadata about their study data, which, in turn, will facilitate
data integration and comparability among studies by decreasing
the likelihood of making errors in the selection of appropriate
data for a study proposal.
The identified observational studies may serve as the basis
for defining case studies on specific nutritional epidemiologic re-
search questions that will test the integration of studies within
the DASH-IN. Case studies will contribute to the optimization
of processes with regard to data access, information technology
infrastructure, solutions for intellectual property issues, meth-
ods of harmonization of existing data, as well as standardiza-
tion of terms and ontologies within a protected environment.
The DASH-IN will 1) show the numerous benefits of con-
necting those nutritional epidemiologic studies of similar design
by creating opportunities for collaborative and multicenter re-
search, 2) increase the efficiency of secondary usage of ex-
isting data, 3) improve the generalizability of results, and 4)
improve the validity of comparative studies. We therefore
envision that the DASH-IN may enhance the capacity of nu-
tritionists, biologists, epidemiologists, and clinicians to carry
out high-impact research with particular emphasis on omics
data (transcriptomics, proteomics, metabolomics) to study the
complex relation and interaction between nutrition and human
health through genes and metabolome profiles (55, 56) once
these data become available.
In conclusion, we identified 26 observational studies in nu-
tritional epidemiology with data on dietary intake, biomarkers,
and health outcomes for federated data analysis. In addition, we
compiled a list of minimal requirements for the development of
a database to store metadata. The minimal requirements and
the identified studies may encourage more efficient secondary
usage of existing data and promote collaboration initiatives to
conduct joint data analysis that may help to better understand
the role of diet and metabolism in the development and preven-
tion of chronic diseases.
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